Retinal Gene Therapies Endpoints Get FDA Advisory Panel Review
This article was originally published in The Pink Sheet Daily
Executive Summary
A collaborative effort between Sanofi-Aventis, Oxford BioMedica and the National Neurovision Research Institute is one example of research in genetic treatments for retinal disorders.